[Synoviorthese]

Area of Science:

• Rheumatology
• Nuclear Medicine
• Orthopedics

Context:

• Rheumatoid synovitis, characterized by joint inflammation, presents challenges for effective local treatment.
• Current local treatments like corticosteroids and cytostatics offer only temporary relief for rheumatoid synovitis.
• Intra-articular osmic acid provides longer control of joint effusions but radionuclide therapy is considered most effective.

Purpose:

• To evaluate the efficacy of radionuclide therapy as a local treatment for rheumatoid synovitis.
• To compare radionuclide therapy with other local treatments, including corticosteroids, cytostatics, osmic acid, and surgical synovectomy.
• To determine the suitability of radionuclide therapy as a conservative alternative, particularly for elderly patients.

Summary:

• Intra-articular corticosteroid injections provide transient symptom relief for rheumatoid synovitis.
• Local cytostatic treatment offers a somewhat longer duration of effect compared to corticosteroids.
• Intra-articular osmic acid effectively controls joint effusions for extended periods.
• Radionuclide therapy emerges as the most effective conservative local treatment for rheumatoid synovitis, offering prolonged control of joint effusions.
• Radionuclide therapy is a viable alternative to surgical synovectomy, especially in older patients.
• Dosage and choice of radionuclides are tailored to joint size, with rare side effects when administered with precautions.

Impact:

• Radionuclide therapy provides a durable, conservative treatment option for rheumatoid synovitis, improving joint effusion management.
• This therapeutic approach can potentially reduce the need for surgical intervention, particularly in vulnerable patient populations.
• The findings support the use of radionuclide therapy as a key strategy in managing chronic joint inflammation and associated symptoms.